Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
01/18/2012 | CN102319236A Application of polygonatum homoisoflavonoid compound in preparing product for treating diabetes mellitus and nephropathy |
01/18/2012 | CN102319235A Application of compound |
01/18/2012 | CN102319234A Application of curcumin in preparation of thyroid carcinoma therapeutic agent |
01/18/2012 | CN102319233A Application of pterostilbene in inhibiting vascular endothelial apoptosis |
01/18/2012 | CN102319232A Mir-133-targeted anti-osteosarcoma small molecular compound |
01/18/2012 | CN102319230A Implantable 5-fluorouracil sustained and controlled release delivery system and preparation method thereof |
01/18/2012 | CN102319229A Preparation method of diclofenac sodium transdermal patch |
01/18/2012 | CN102319228A Dutasteride liquid hard capsule and preparation method thereof |
01/18/2012 | CN102319227A Lomerizine hydrochloride osmotic pump tablet and preparation method thereof |
01/18/2012 | CN102319226A Reboxetine mesylate microencapsule tablet and preparation method thereof |
01/18/2012 | CN102319225A Trimetazidine hydrochloride sustained release tablet and preparation method thereof |
01/18/2012 | CN102319224A Compound methoxyphenamine rapid-release slow-release osmotic pump preparation |
01/18/2012 | CN102319223A Esomeprazole freeze-dried preparation and preparation method thereof |
01/18/2012 | CN102319222A Decitabine freeze-dried preparation and preparation method thereof |
01/18/2012 | CN102319221A Cefsulodin sodium lyophilized powder, cefsulodin sodium lyophilized powder preparation and their preparation method |
01/18/2012 | CN102319219A Chitosan nanoparticle preparation of ceftiofur sodium, and preparation method thereof |
01/18/2012 | CN102319218A Drug sustained and controlled release microparticle preparation for treating intestinal diseases, and preparation method thereof |
01/18/2012 | CN102319217A Polysaccharide coated magnetic nano-particle and preparation method |
01/18/2012 | CN102319215A Vecuronium bromide liposome injection |
01/18/2012 | CN102319214A Lipid microsphere injection containing sodium demethyl cantharidate-phosphatide complex and preparation method thereof |
01/18/2012 | CN102319213A Beraprost acid nanolipid microsphere preparation |
01/18/2012 | CN102319212A Clevidipine butyrate structured lipid emulsion and preparation method thereof |
01/18/2012 | CN102319211A Preparation process and application of tryptanthrin injection emulsion |
01/18/2012 | CN102319210A Veterinary long-acting cefquinome sulfate injection and preparation method thereof |
01/18/2012 | CN102319209A Nasal pharmaceutical formulations and methods of using the same |
01/18/2012 | CN102319208A Suspension composition for treating oral mucositis caused by chemoradiotherapy |
01/18/2012 | CN102319207A 42-(dimethylphosphinate) rapamycin liquid composition |
01/18/2012 | CN102319205A Ibuprofen injection and preparation method thereof |
01/18/2012 | CN102319204A Azithromycin ophthalmic preparation drug composition and preparation method thereof |
01/18/2012 | CN102319203A Preparation method of levofloxacin lactate and sodium chloride injection |
01/18/2012 | CN102319202A Mometasone furoate gel and preparation method thereof |
01/18/2012 | CN102319181A Enveloping process for micro-capsule animal medicament |
01/18/2012 | CN102319180A Preparation methods of ligustrazine nanoparticle solution and spraying agent thereof |
01/18/2012 | CN102318604A Ant spray containing d-limonene |
01/18/2012 | CN102078483B Chinese patent medicine (Bezoar Qianliekang Turunda) for treating prostate disease and preparation method thereof |
01/18/2012 | CN102068617B Pure Chinese herbal medicine inflammation-diminishing and sterilizing suspension liniment and preparation method thereof |
01/18/2012 | CN102048787B Traditional Chinese medicine preparation for treating degenerative joint disease and preparation method thereof |
01/18/2012 | CN102018668B Preparation method of aceglutamide |
01/18/2012 | CN101926868B External traditional Chinese medicine for preventing and treating phlebitis caused by chemotherapeutic medicines |
01/18/2012 | CN101926756B Solid preparation of clopidogrel or pharmaceutically acceptable salt thereof |
01/18/2012 | CN101921224B 1-(3-aminopropyl) piperazine-4-aminoamide compound as well as preparation method and application thereof |
01/18/2012 | CN101891834B Polysaccharide sulfate fragment (PSC), preparation method and application thereof |
01/18/2012 | CN101884623B Levodopa methyl ester slow-release microsphere composition and preparation method thereof |
01/18/2012 | CN101884622B Benserazide sustained-release microspherical composition and preparation method thereof |
01/18/2012 | CN101884611B Method for preparing medicinal invert sugar by sugar hydrolysis |
01/18/2012 | CN101879184B Medicinal composition for improving reproductive capability and preparation method and application thereof |
01/18/2012 | CN101863871B Total glycosides of Rhodiola rosea, medical application and preparation method thereof |
01/18/2012 | CN101836998B Application of tyrosol glucoside in preparing anti-hemorrhagic shock drug |
01/18/2012 | CN101829260B Chinese medicine sachet for preventing and treating influenza and preparation method thereof |
01/18/2012 | CN101829077B Application of dicaffeoyl-quinic acid derivative in preparing drugs for treating mycoplasma infection diseases |
01/18/2012 | CN101816669B Composition containing gentamicin and borneol and use thereof |
01/18/2012 | CN101810665B Use of yuenkanin organic acid for preparing weight-losing and blood lipid-lowering medicine |
01/18/2012 | CN101810664B Use of yuenkanin total saponins for preparing weight-losing and blood lipid-lowering medicine |
01/18/2012 | CN101804089B Use of total flavonoids from radix Daphne genkwa in preparing weight-losing hypolipemic drugs |
01/18/2012 | CN101797243B Composition containing levodopa and borneol, and application thereof |
01/18/2012 | CN101791371B Method for preparing saponin by extracting asparagus officinalis L |
01/18/2012 | CN101695487B Polyenoic ethyl ester emulsion of high-purity EPA-E and DHA-E |
01/18/2012 | CN101695478B Tamsulosin hydrochloride sustained-release pellets and preparation method thereof |
01/18/2012 | CN101674829B Use of 4-cyclopropylmethoxy-n-(3,5-dichloro-1-oxidopyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide for the treatment of spinal cord traumas |
01/18/2012 | CN101670008B Deer fetus film and manufacturing method thereof |
01/18/2012 | CN101638384B Novel carbostyril compound, preparation and application thereof |
01/18/2012 | CN101590223B SOD complex capsule and preparation method thereof |
01/18/2012 | CN101538191B Synthetic method of high-purity propofol |
01/18/2012 | CN101531613B Aminopeptidase N inhibitor bestatin dino ester, synthesis and application thereof |
01/18/2012 | CN101522195B Pharmaceutical composition comprising phenylamidine derivative and method of using the pharmaceutical composition in combination with antifungal agent |
01/18/2012 | CN101500551B Compositions containing chalcones and use thereof |
01/18/2012 | CN101491670B Method for treating cardiovascular disease using nervous regulation protein and composite |
01/18/2012 | CN101473999B Health-care type electronic smoke liquid for preventing and treating decayed tooth |
01/18/2012 | CN101461566B Atomized liquid of electronic smoke |
01/18/2012 | CN101461565B Medicinal health type tobacco juice for electronic smoke |
01/18/2012 | CN101450075B Hydroxyethyl starch 130/0.4 sodium chloride injection and preparation method and use thereof |
01/18/2012 | CN101410098B Microspheres comprising nanocapsules containing a lipophilicdrug |
01/18/2012 | CN101406478B Pharmaceutical composition for reducing homosysteine |
01/18/2012 | CN101406466B Cinnamic acid transdermal patch and preparation technique thereof |
01/18/2012 | CN101390871B Ginsenoside Rb1 containing impurity ginsenoside Rd |
01/18/2012 | CN101327198B Thiazolidinedione metallic salt medicament enteric-coated formulation and preparation method thereof |
01/18/2012 | CN101304969B Benzene derivative or salt thereof |
01/18/2012 | CN101278919B Metformin hydrochloride and Glipizide sustained-release pellet and method of preparing the same |
01/18/2012 | CN101238123B Imidazo- and triazolopyridines as inhibitors of 11-beta hydroxysteroid dehyftogenase type I |
01/18/2012 | CN101163692B Heterocyclic substituted piperazines with cxcr3 antagonist activity |
01/18/2012 | CN101155591B Glucosamine and derivatives thereof useful as tg inhibitors |
01/18/2012 | CN101107226B Phenoxyacetic acid derivatives useful for treating respiratory diseases |
01/18/2012 | CN101087754B Novel cyclohexane derivatives |
01/17/2012 | US8097759 Inflammatory cytokine release inhibitor |
01/17/2012 | US8097758 Isoserine derivatives for use as coagulation factor IXa inhibitors |
01/17/2012 | US8097752 Antiprotozoal ring-substituted phospholipids |
01/17/2012 | US8097734 Crystalline sodium atorvastatin |
01/17/2012 | US8097732 e.g. 5-amino-1-[2,6-dichloro-4-(trifluoromethyl)phenyl]-4-(1,3-dithiolan-2-yl)-1H-pyrazole-3-carbonitrile; controlling pests, especially by treatment of domestic animals |
01/17/2012 | US8097729 Polymorphic form of lercanidipine hydrochloride and process for the preparation thereof |
01/17/2012 | US8097726 Huperzine a compound for treatment of alzheimer's disease |
01/17/2012 | US8097718 3,5-disubstituted and 3,5,7-trisubstituted-3H-oxazolo and 3H-thiazolo[4,5-d]pyrimidin-2-one compounds and prodrugs thereof |
01/17/2012 | US8097715 Multitargeting interfering RNAs having two active strands and methods for their design and use |
01/17/2012 | US8097711 nucleoside monomers protected with thioether substituted aryl carbonate protecting groups; oligonucleotides, using such protected nucleoside monomer monomers, as well as nucleic acids |
01/17/2012 | US8097709 Macrolactam compounds |
01/17/2012 | US8097656 Nitrogenated trans-stilbene analogs, method for the obtention and medical applications thereof |
01/17/2012 | US8097655 Methods for concomitant administration of colchicine and macrolide antibiotics |
01/17/2012 | US8097654 Radiolabeled 3-[3-(benzoyl-amido)benzyloxy]aspartic acid derivative and method of producing the same |
01/17/2012 | US8097653 Dosage unit comprising a prostaglandin analog for treating constipation |
01/17/2012 | US8097652 AMPA receptor potentiators |
01/17/2012 | US8097651 Diclofenac formulations and methods of use |